Samsung Epis opens 1st overseas R&D center in China

Samsung Epis Holdings has opened its first overseas research and development office in Beijing, looking to leverage the local talent and infrastructure to speed up new drug discovery. According to Samsung Epis Holdings on Wednesday, it held an official opening ceremony for Samsung Bioepis China on the previous day. In May, the firm announced that it had recently set up Samsung Bioepis China, a fully owned subsidiary, in Beijing’s Changping district, without disclosing the size of the investment.

2026-07-01 13:49:16:00

Minimum wage gap narrows, but breakthrough still elusive

Labor and business representatives narrowed their differences over next year's minimum wage after submitting a second round of revised proposals, but negotiations remained deadlocked with the two sides still 1,540 won ($1) apart. The labor side proposed raising the hourly minimum wage to 11,900 won, while the employer side offered 10,360 won during the Minimum Wage Commission’s meeting at the government complex in Sejong on Tuesday. Although the latest proposals narrowed the gap from the initial

2026-06-30 21:02:51:00

Homeplus, Korea Zinc unions join forces to condemn MBK Partners

The labor unions of Homeplus and Korea Zinc have teamed up for the first time to intensify the pressure on private equity firm MBK Partners, accusing it of prioritizing profits over workers and long-term corporate sustainability. The two groups stressed that Homeplus' ongoing corporate rehabilitation and MBK's attempt to gain control of Korea Zinc are manifestations of the same problem during a joint press conference at a Homeplus hunger strike site in Gwanghawmun Square, central Seoul, on Tuesd

2026-06-30 20:35:25:00

Wemade sold to China-linked NeoPulse for W920b

Wemade — a Korean game developer known for its hit massively multiplayer online role-playing game, or MMORPG, franchise the Legend of Mir — has been sold to China linked company NeoPulse. According to Wemade on Tuesday, founder Park Kwan-ho signed a stock purchase agreement with NeoPulse, a Korean subsidiary of Hong Kong-based investment company Shengsong Investment, to sell his entire 39.33 percent stake in Wemade worth about 920 billion won ($593 million). Once the stock purchase is complete o

2026-06-30 19:35:31:00

Inside Lilly's biotech startup factory

SAN DIEGO — Inside the social room on the second floor of a building at Lilly Gateway Labs in San Diego, researchers and scientists gathered in separate groups, casually discussing ongoing projects or sharing lunchtime conversation on Thursday. Next door to the spacious, comfortable social room was a module — a combination of an office space and a laboratory — of a resident biotechnology firm. "Our philosophy is that the access to our scientific leadership and expertise is just as valuable as th

2026-06-29 12:57:43:00

[Bio USA] Celltiron posts record showing at BIO International Convention

SAN DIEGO — Celltrion has expanded its global partnering efforts with its artificial intelligence-powered drug discovery capabilities and next-generation biologics pipeline at the BIO International Convention 2026 in San Diego this week, the Korean biosimilar company said Thursday. This year’s convention, arguably the world’s largest biopharmaceutical and biotechnology showcase, drew approximately 20,000 participants from more than 68 countries, including over 1,600 exhibitors. Celltrion reporte

2026-06-26 11:10:23:00

[Bio USA] Samsung Biologics steps up CDMO tech race

SAN DIEGO — Samsung Biologics is accelerating research and development efforts to strengthen its position in the contract development and manufacturing organization market by leveraging proprietary platforms, next-generation modalities and strategic technology investments. “Supporting core technology for contract development business is the most important task at (Samsung Biologics’ Bio R&D Center),” Jeong Hyeong-nam, chief of Samsung Biologics’ Bio R&D Center, said at press conference at the BI

2026-06-25 14:31:20:00

[Bio USA] Lotte Biologics eyes more CDMO orders with Songdo Plant 1

SAN DIEGO -- Lotte Biologics is zeroing in on securing more orders and expanding its global presence with the completion of Plant 1’s construction and approval for use at its Songdo Bio Campus in Incheon. “Lotte Biologics has now secured a dual-site production system in the United States and Korea,” said James Park, CEO of Lotte Biologics, in a press conference held on the sidelines of the BIO International Convention in San Diego on Tuesday. “Based on the Songdo Bio Campus’ Plant 1 and the Syra

2026-06-25 12:00:00:00

[Bio USA] Samsung Biologics to open first European sales office in Amsterdam

SAN DIEGO – Samsung Biologics will establish its first official European sales office in Amsterdam, as the leading Korean contract development and manufacturing organization, or CDMO, looks to continue expanding its global presence. “We are planning to open the European sales office in the third quarter of this year,” said John Rim, CEO of Samsung Biologics, in a press conference held on the sidelines of the BIO International Convention in San Diego on Tuesday. “Located at the center of Europe,

2026-06-24 17:00:00:00

[Bio USA] Korean biotech has innovation. Now it needs capital

SAN DIEGO – Korea’s biotechnology industry has rapidly emerged as one of Asia's most promising innovation ecosystems, but industry experts say securing global capital and adopting more flexible business models remain critical challenges if the country hopes to position itself as a global biotech powerhouse. “Korea is already an innovation hub,” said Hwang Jurie, director of public and international affairs at the Korea Biotechnology Industry Organization, or KoreaBIO, during a panel discussion t

2026-06-24 15:30:11:00